155 related articles for article (PubMed ID: 30178833)
41. Bcl-2 protein expression is associated with p27 and p53 protein expressions and MIB-1 counts in breast cancer.
Tsutsui S; Yasuda K; Suzuki K; Takeuchi H; Nishizaki T; Higashi H; Era S
BMC Cancer; 2006 Jul; 6():187. PubMed ID: 16839413
[TBL] [Abstract][Full Text] [Related]
42. [Prognostic significance of expression of p53, bcl-2 and bax in squamous epithelial carcinoma of the larynx--a multivariate analysis].
Jäckel MC; Sellmann L; Youssef S; Dorudian MA; Füzesi L
HNO; 2001 Mar; 49(3):204-11. PubMed ID: 11320623
[TBL] [Abstract][Full Text] [Related]
43. [Expression of apoptosis and proliferation markers in progression of ovarian cancer].
Antoneeva II; Petrov SB
Patol Fiziol Eksp Ter; 2008; (4):6-7. PubMed ID: 19198263
[TBL] [Abstract][Full Text] [Related]
44. High α B-crystallin and p53 co-expression is associated with poor prognosis in ovarian cancer.
Tan L; Sha L; Hou N; Zhang M; Ma Q; Shi C
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31152111
[TBL] [Abstract][Full Text] [Related]
45. Prognostic significance of HER-2, p53 and Bcl-2 in patients with epithelial ovarian cancer.
Malamou-Mitsi V; Crikoni O; Timotheadou E; Aravantinos G; Vrettou E; Agnantis N; Fountzilas G
Anticancer Res; 2007; 27(2):1157-65. PubMed ID: 17465257
[TBL] [Abstract][Full Text] [Related]
46. Tomm34 is commonly expressed in epithelial ovarian cancer and associates with tumour type and high FIGO stage.
Muller P; Coates PJ; Nenutil R; Trcka F; Hrstka R; Chovanec J; Brychtova V; Vojtesek B
J Ovarian Res; 2019 Mar; 12(1):30. PubMed ID: 30917858
[TBL] [Abstract][Full Text] [Related]
47. The prognostic and predictive value of ERCC-1, p53, bcl-2 and bax in epithelial ovarian cancer.
Avraam K; Pavlakis K; Papadimitriou C; Vrekoussis T; Panoskaltsis T; Messini I; Patsouris E
Eur J Gynaecol Oncol; 2011; 32(5):516-20. PubMed ID: 22053665
[TBL] [Abstract][Full Text] [Related]
48. Prognostic significance of Bcl-2 and p53 expression in gastric cancer.
Lee HK; Lee HS; Yang HK; Kim WH; Lee KU; Choe KJ; Kim JP
Int J Colorectal Dis; 2003 Nov; 18(6):518-25. PubMed ID: 12811476
[TBL] [Abstract][Full Text] [Related]
49. The AIB1 gene polyglutamine repeat length polymorphism contributes to risk of epithelial ovarian cancer risk: a case-control study.
Han G; Xie S; Fang H; Li G; Han Y; Qin Z
Tumour Biol; 2015 Jan; 36(1):371-4. PubMed ID: 25263716
[TBL] [Abstract][Full Text] [Related]
50. Expression of survivin, bcl-2, P53 and bax in breast carcinoma and ductal intraepithelial neoplasia (DIN 1a).
Kayaselcuk F; Nursal TZ; Polat A; Noyan T; Yildirim S; Tarim A; Seydaoglu G
J Exp Clin Cancer Res; 2004 Mar; 23(1):105-12. PubMed ID: 15149158
[TBL] [Abstract][Full Text] [Related]
51. Upregulation of cyclase-associated actin cytoskeleton regulatory protein 2 in epithelial ovarian cancer correlates with aggressive histologic types and worse outcomes.
Adachi M; Masugi Y; Yamazaki K; Emoto K; Kobayashi Y; Tominaga E; Banno K; Aoki D; Sakamoto M
Jpn J Clin Oncol; 2020 Jun; 50(6):643-652. PubMed ID: 32211793
[TBL] [Abstract][Full Text] [Related]
52. p53 and related proteins in epithelial ovarian cancer.
Sengupta PS; McGown AT; Bajaj V; Blackhall F; Swindell R; Bromley M; Shanks JH; Ward T; Buckley CH; Reynolds K; Slade RJ; Jayson GC
Eur J Cancer; 2000 Dec; 36(18):2317-28. PubMed ID: 11094305
[TBL] [Abstract][Full Text] [Related]
53. THE PROGNOSTIC SIGNIFICANCE OF P53, BCL2 AND MIB1 EXPRESSIONS RELATED WITH OTHER CLINICOPATHOLOGICAL VARIABLES IN SEROUS OVARIAN CARCINOMAS. A CLINICOPATHOLOGICAL STUDY IN PERITONEAL FLUIDS.
Kalogeraki A; Tamiolakis D; Matalliotaki C; Karvela-Kalogeraki I; Karvelas-Kalogerakis M; Segredakis J; Sinatkas V; Matalliotakis I
Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):454-60. PubMed ID: 26204652
[TBL] [Abstract][Full Text] [Related]
54. Expression of pro-apoptotic (p53, p21, bax, bak and fas) and anti-apoptotic (bcl-2 and bcl-x) proteins in serous versus mucinous borderline ovarian tumours.
Fauvet R; Dufournet C; Poncelet C; Uzan C; Hugol D; Daraï E
J Surg Oncol; 2005 Dec; 92(4):337-43. PubMed ID: 16299808
[TBL] [Abstract][Full Text] [Related]
55. bcl-2 protein expression is associated with a prognostically favourable phenotype in breast cancer irrespective of p53 immunostaining.
Nakopoulou L; Michalopoulou A; Giannopoulou I; Tzonou A; Keramopoulos A; Lazaris AC; Davaris PS
Histopathology; 1999 Apr; 34(4):310-9. PubMed ID: 10231398
[TBL] [Abstract][Full Text] [Related]
56. Steroid receptors and hormones in relation to cell proliferation and apoptosis in poorly differentiated epithelial ovarian tumors.
Lindgren P; Bäckström T; Mählck CG; Ridderheim M; Cajander S
Int J Oncol; 2001 Jul; 19(1):31-8. PubMed ID: 11408919
[TBL] [Abstract][Full Text] [Related]
57. p53 and mdm2 as prognostic indicators in patients with epithelial ovarian cancer: a multivariate analysis.
Dogan E; Saygili U; Tuna B; Gol M; Gürel D; Acar B; Koyuncuoğlu M
Gynecol Oncol; 2005 Apr; 97(1):46-52. PubMed ID: 15790436
[TBL] [Abstract][Full Text] [Related]
58. The impact of c-kit and ki-67 expression on patients prognosis in advanced ovarian serous carcinoma.
Khalifeh I; Munkarah AR; Schimp V; Morris R; Lawrence WD; Ali-Fehmi R
Int J Gynecol Pathol; 2005 Jul; 24(3):228-34. PubMed ID: 15968197
[TBL] [Abstract][Full Text] [Related]
59. Expression of Interactive Genes Associated with Apoptosis and Their Prognostic Value for Ovarian Serous Adenocarcinoma.
Shin K; Kim KH; Yoon MS; Suh DS; Lee JY; Kim A; Eo W
Adv Clin Exp Med; 2016; 25(3):513-21. PubMed ID: 27629740
[TBL] [Abstract][Full Text] [Related]
60. [The study of the expression, effect and clinical relationship of TGF-beta1 CD44V6 bcl-2 and p53 in the larynx squamous carcinoma].
Huang Z; Deng H; Feng X; Zhang F; Jiang J; Liu D
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Dec; 18(12):733-6. PubMed ID: 15831046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
